Click for best price
Nanobiotechnology Market Size, Share 2022
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
This report contains market size and forecasts of Nanobiotechnology in Global, including the following market information:
Global Nanobiotechnology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nanobiotechnology market was valued at 69170 million in 2021 and is projected to reach US$ 103620 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nanomedicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nanobiotechnology include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nanobiotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanobiotechnology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nanobiotechnology Market Segment Percentages, by Type, 2021 (%)
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Global Nanobiotechnology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nanobiotechnology Market Segment Percentages, by Application, 2021 (%)
Anticancer
CNS Product
Anti-infective
Other
Global Nanobiotechnology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nanobiotechnology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanobiotechnology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nanobiotechnology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
| Report Attributes |
Report Details |
| Report Title |
Nanobiotechnology Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nanobiotechnology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanobiotechnology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanobiotechnology Overall Market Size
2.1 Global Nanobiotechnology Market Size: 2021 VS 2028
2.2 Global Nanobiotechnology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanobiotechnology Players in Global Market
3.2 Top Global Nanobiotechnology Companies Ranked by Revenue
3.3 Global Nanobiotechnology Revenue by Companies
3.4 Top 3 and Top 5 Nanobiotechnology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nanobiotechnology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanobiotechnology Players in Global Market
3.6.1 List of Global Tier 1 Nanobiotechnology Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanobiotechnology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nanobiotechnology Market Size Markets, 2021 & 2028
4.1.2 Nanomedicine
4.1.3 Nano Medical Devices
4.1.4 Nano Diagnosis
4.1.5 Other
4.2 By Type - Global Nanobiotechnology Revenue & Forecasts
4.2.1 By Type - Global Nanobiotechnology Revenue, 2017-2022
4.2.2 By Type - Global Nanobiotechnology Revenue, 2023-2028
4.2.3 By Type - Global Nanobiotechnology Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanobiotechnology Market Size, 2021 & 2028
5.1.2 Anticancer
5.1.3 CNS Product
5.1.4 Anti-infective
5.1.5 Other
5.2 By Application - Global Nanobiotechnology Revenue & Forecasts
5.2.1 By Application - Global Nanobiotechnology Revenue, 2017-2022
5.2.2 By Application - Global Nanobiotechnology Revenue, 2023-2028
5.2.3 By Application - Global Nanobiotechnology Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nanobiotechnology Market Size, 2021 & 2028
6.2 By Region - Global Nanobiotechnology Revenue & Forecasts
6.2.1 By Region - Global Nanobiotechnology Revenue, 2017-2022
6.2.2 By Region - Global Nanobiotechnology Revenue, 2023-2028
6.2.3 By Region - Global Nanobiotechnology Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nanobiotechnology Revenue, 2017-2028
6.3.2 US Nanobiotechnology Market Size, 2017-2028
6.3.3 Canada Nanobiotechnology Market Size, 2017-2028
6.3.4 Mexico Nanobiotechnology Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nanobiotechnology Revenue, 2017-2028
6.4.2 Germany Nanobiotechnology Market Size, 2017-2028
6.4.3 France Nanobiotechnology Market Size, 2017-2028
6.4.4 U.K. Nanobiotechnology Market Size, 2017-2028
6.4.5 Italy Nanobiotechnology Market Size, 2017-2028
6.4.6 Russia Nanobiotechnology Market Size, 2017-2028
6.4.7 Nordic Countries Nanobiotechnology Market Size, 2017-2028
6.4.8 Benelux Nanobiotechnology Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nanobiotechnology Revenue, 2017-2028
6.5.2 China Nanobiotechnology Market Size, 2017-2028
6.5.3 Japan Nanobiotechnology Market Size, 2017-2028
6.5.4 South Korea Nanobiotechnology Market Size, 2017-2028
6.5.5 Southeast Asia Nanobiotechnology Market Size, 2017-2028
6.5.6 India Nanobiotechnology Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nanobiotechnology Revenue, 2017-2028
6.6.2 Brazil Nanobiotechnology Market Size, 2017-2028
6.6.3 Argentina Nanobiotechnology Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nanobiotechnology Revenue, 2017-2028
6.7.2 Turkey Nanobiotechnology Market Size, 2017-2028
6.7.3 Israel Nanobiotechnology Market Size, 2017-2028
6.7.4 Saudi Arabia Nanobiotechnology Market Size, 2017-2028
6.7.5 UAE Nanobiotechnology Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Nanobiotechnology Major Product Offerings
7.1.4 Amgen Nanobiotechnology Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Corporate Summary
7.2.2 Teva Pharmaceuticals Business Overview
7.2.3 Teva Pharmaceuticals Nanobiotechnology Major Product Offerings
7.2.4 Teva Pharmaceuticals Nanobiotechnology Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceuticals Key News
7.3 Abbott
7.3.1 Abbott Corporate Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Nanobiotechnology Major Product Offerings
7.3.4 Abbott Nanobiotechnology Revenue in Global Market (2017-2022)
7.3.5 Abbott Key News
7.4 UCB
7.4.1 UCB Corporate Summary
7.4.2 UCB Business Overview
7.4.3 UCB Nanobiotechnology Major Product Offerings
7.4.4 UCB Nanobiotechnology Revenue in Global Market (2017-2022)
7.4.5 UCB Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nanobiotechnology Major Product Offerings
7.5.4 Roche Nanobiotechnology Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Nanobiotechnology Major Product Offerings
7.6.4 Celgene Nanobiotechnology Revenue in Global Market (2017-2022)
7.6.5 Celgene Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Nanobiotechnology Major Product Offerings
7.7.4 Sanofi Nanobiotechnology Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 Merck & Co
7.8.1 Merck & Co Corporate Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Nanobiotechnology Major Product Offerings
7.8.4 Merck & Co Nanobiotechnology Revenue in Global Market (2017-2022)
7.8.5 Merck & Co Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Nanobiotechnology Major Product Offerings
7.9.4 Biogen Nanobiotechnology Revenue in Global Market (2017-2022)
7.9.5 Biogen Key News
7.10 Stryker
7.10.1 Stryker Corporate Summary
7.10.2 Stryker Business Overview
7.10.3 Stryker Nanobiotechnology Major Product Offerings
7.10.4 Stryker Nanobiotechnology Revenue in Global Market (2017-2022)
7.10.5 Stryker Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Business Overview
7.11.3 Gilead Sciences Nanobiotechnology Major Product Offerings
7.11.4 Gilead Sciences Nanobiotechnology Revenue in Global Market (2017-2022)
7.11.5 Gilead Sciences Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Nanobiotechnology Major Product Offerings
7.12.4 Pfizer Nanobiotechnology Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 3M Company
7.13.1 3M Company Corporate Summary
7.13.2 3M Company Business Overview
7.13.3 3M Company Nanobiotechnology Major Product Offerings
7.13.4 3M Company Nanobiotechnology Revenue in Global Market (2017-2022)
7.13.5 3M Company Key News
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Corporate Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Nanobiotechnology Major Product Offerings
7.14.4 Johnson & Johnson Nanobiotechnology Revenue in Global Market (2017-2022)
7.14.5 Johnson & Johnson Key News
7.15 Smith & Nephew
7.15.1 Smith & Nephew Corporate Summary
7.15.2 Smith & Nephew Business Overview
7.15.3 Smith & Nephew Nanobiotechnology Major Product Offerings
7.15.4 Smith & Nephew Nanobiotechnology Revenue in Global Market (2017-2022)
7.15.5 Smith & Nephew Key News
7.16 Leadiant Biosciences
7.16.1 Leadiant Biosciences Corporate Summary
7.16.2 Leadiant Biosciences Business Overview
7.16.3 Leadiant Biosciences Nanobiotechnology Major Product Offerings
7.16.4 Leadiant Biosciences Nanobiotechnology Revenue in Global Market (2017-2022)
7.16.5 Leadiant Biosciences Key News
7.17 Kyowa Hakko Kirin
7.17.1 Kyowa Hakko Kirin Corporate Summary
7.17.2 Kyowa Hakko Kirin Business Overview
7.17.3 Kyowa Hakko Kirin Nanobiotechnology Major Product Offerings
7.17.4 Kyowa Hakko Kirin Nanobiotechnology Revenue in Global Market (2017-2022)
7.17.5 Kyowa Hakko Kirin Key News
7.18 Shire
7.18.1 Shire Corporate Summary
7.18.2 Shire Business Overview
7.18.3 Shire Nanobiotechnology Major Product Offerings
7.18.4 Shire Nanobiotechnology Revenue in Global Market (2017-2022)
7.18.5 Shire Key News
7.19 Ipsen
7.19.1 Ipsen Corporate Summary
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Nanobiotechnology Major Product Offerings
7.19.4 Ipsen Nanobiotechnology Revenue in Global Market (2017-2022)
7.19.5 Ipsen Key News
7.20 Endo International
7.20.1 Endo International Corporate Summary
7.20.2 Endo International Business Overview
7.20.3 Endo International Nanobiotechnology Major Product Offerings
7.20.4 Endo International Nanobiotechnology Revenue in Global Market (2017-2022)
7.20.5 Endo International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nanobiotechnology Market Opportunities & Trends in Global Market
Table 2. Nanobiotechnology Market Drivers in Global Market
Table 3. Nanobiotechnology Market Restraints in Global Market
Table 4. Key Players of Nanobiotechnology in Global Market
Table 5. Top Nanobiotechnology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nanobiotechnology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nanobiotechnology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nanobiotechnology Product Type
Table 9. List of Global Tier 1 Nanobiotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanobiotechnology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nanobiotechnology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nanobiotechnology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nanobiotechnology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Nanobiotechnology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nanobiotechnology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nanobiotechnology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Nanobiotechnology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nanobiotechnology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nanobiotechnology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nanobiotechnology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nanobiotechnology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nanobiotechnology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nanobiotechnology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nanobiotechnology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nanobiotechnology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nanobiotechnology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nanobiotechnology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nanobiotechnology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nanobiotechnology Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Nanobiotechnology Product Offerings
Table 32. Amgen Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceuticals Corporate Summary
Table 34. Teva Pharmaceuticals Nanobiotechnology Product Offerings
Table 35. Teva Pharmaceuticals Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Corporate Summary
Table 37. Abbott Nanobiotechnology Product Offerings
Table 38. Abbott Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 39. UCB Corporate Summary
Table 40. UCB Nanobiotechnology Product Offerings
Table 41. UCB Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Nanobiotechnology Product Offerings
Table 44. Roche Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 45. Celgene Corporate Summary
Table 46. Celgene Nanobiotechnology Product Offerings
Table 47. Celgene Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Nanobiotechnology Product Offerings
Table 50. Sanofi Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co Corporate Summary
Table 52. Merck & Co Nanobiotechnology Product Offerings
Table 53. Merck & Co Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 54. Biogen Corporate Summary
Table 55. Biogen Nanobiotechnology Product Offerings
Table 56. Biogen Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 57. Stryker Corporate Summary
Table 58. Stryker Nanobiotechnology Product Offerings
Table 59. Stryker Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 60. Gilead Sciences Corporate Summary
Table 61. Gilead Sciences Nanobiotechnology Product Offerings
Table 62. Gilead Sciences Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Nanobiotechnology Product Offerings
Table 65. Pfizer Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 66. 3M Company Corporate Summary
Table 67. 3M Company Nanobiotechnology Product Offerings
Table 68. 3M Company Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 69. Johnson & Johnson Corporate Summary
Table 70. Johnson & Johnson Nanobiotechnology Product Offerings
Table 71. Johnson & Johnson Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 72. Smith & Nephew Corporate Summary
Table 73. Smith & Nephew Nanobiotechnology Product Offerings
Table 74. Smith & Nephew Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 75. Leadiant Biosciences Corporate Summary
Table 76. Leadiant Biosciences Nanobiotechnology Product Offerings
Table 77. Leadiant Biosciences Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 78. Kyowa Hakko Kirin Corporate Summary
Table 79. Kyowa Hakko Kirin Nanobiotechnology Product Offerings
Table 80. Kyowa Hakko Kirin Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 81. Shire Corporate Summary
Table 82. Shire Nanobiotechnology Product Offerings
Table 83. Shire Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 84. Ipsen Corporate Summary
Table 85. Ipsen Nanobiotechnology Product Offerings
Table 86. Ipsen Nanobiotechnology Revenue (US$, Mn), (2017-2022)
Table 87. Endo International Corporate Summary
Table 88. Endo International Nanobiotechnology Product Offerings
Table 89. Endo International Nanobiotechnology Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nanobiotechnology Segment by Type in 2021
Figure 2. Nanobiotechnology Segment by Application in 2021
Figure 3. Global Nanobiotechnology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nanobiotechnology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nanobiotechnology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanobiotechnology Revenue in 2021
Figure 8. By Type - Global Nanobiotechnology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nanobiotechnology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nanobiotechnology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nanobiotechnology Revenue Market Share, 2017-2028
Figure 12. US Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nanobiotechnology Revenue Market Share, 2017-2028
Figure 16. Germany Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 17. France Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nanobiotechnology Revenue Market Share, 2017-2028
Figure 24. China Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 28. India Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nanobiotechnology Revenue Market Share, 2017-2028
Figure 30. Brazil Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nanobiotechnology Revenue Market Share, 2017-2028
Figure 33. Turkey Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nanobiotechnology Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceuticals Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. UCB Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celgene Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biogen Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stryker Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Gilead Sciences Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Pfizer Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. 3M Company Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Johnson & Johnson Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Smith & Nephew Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Leadiant Biosciences Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Kyowa Hakko Kirin Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Shire Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Ipsen Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Endo International Nanobiotechnology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
